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Lingual Thyroid Ectopia:
Diagnostic SPECT/CT Imaging and Radioactive
Iodine Treatment
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Background: Lingual thyroid is a rare abnormality of thyroid development that is usually treated conservatively
with levothyroxine replacement. Rarely, it becomes large enough to cause obstructive symptoms in the oral
cavity, requiring definitive treatment.
Patient Findings: This study reports on three patients with lingual thyroid treated with radioactive iodine-131
(131I) with successful radioablation of their ectopic thyroid tissues. Measurement of 24-hour radioactive iodine
uptake within thyroidal tissues and hybrid single-photon emission computed tomography/computed tomography
imaging using either iodine-123 or technetium-99m pertechnetate scans were performed in all patients dem-
onstrating the location and size of lingual thyroid and absence of an orthotopic thyroid gland.
Summary: The aim of this study was to describe nonsurgical management of obstructive lingual thyroid tissue
with 131I therapy for lingual thyroid radioablation. Patients were prepared with a low-iodine diet and le-
vothyroxine withdrawal prior to radioablation for optimizing 131I uptake in ectopic thyroid tissues. Hybrid
single-photon emission computed tomography/computed tomography measurement of anatomic size of lingual
thyroid tissue and radioactive iodine uptake guided the selection of therapeutic doses, resulting in adminis-
tration of 10.7, 17.5, and 15.4 mCi of 131I, respectively. There were no post-therapy complications, and clinical
follow-up demonstrated resolution of obstructive oropharyngeal symptoms.
Conclusions: Ectopic lingual thyroid tissue is rarely associated with obstructive oropharyngeal symptoms due
to progressive enlargement. Radioiodine therapy with 131I is an effective treatment modality for ablation of
ectopic thyroid tissue as an alternative to surgery.
Introduction
L ingual thyroid is a rare congenital disorder of thy-roid development, accounting for 90% of cases of ec-
topic thyroid tissue (1,2). It is four times more prevalent in
women (3), and often is diagnosed at birth or in early child-
hood (4). In 75% of cases, there is absence of the orthotopic
thyroid gland, with lingual thyroid tissue as the only source
of thyroid hormone (1). Persons with lingual thyroid are
usually asymptomatic, and management is conservative. In
approximately 70% of cases, lingual thyroid is associated
with hypothyroidism, requiring thyroid hormone replacement,
resulting in involution of ectopic glandular thyroid tissue at the
tongue base (5–7). However, a minority present with ob-
structive oropharyngeal symptoms, such as cough, pain, dys-
phagia, dysphonia, and dyspnea, if the ectopic thyroid tissue
becomes sufficiently large, despite adequate thyroxine re-
placement and suppression of thyrotropin (TSH) (1).
This study reports on three patients with lingual thyroid
referred to the authors’ division for consideration of radioac-
tive iodine-131 (131I) therapy following endocrine or otolar-
yngology surgical consultation. The University of Michigan
Institutional Review Board approved the retrospective review
of medical records. There were no immediate post-radioiodine
therapy complications, and in two patients, there was suc-
cessful ablation of their ectopic thyroid tissue with radioactive
131I, thereby avoiding surgery. The third patient had surgical
resection of a thyroglossal duct mass followed by radioiodine
treatment of a lingual thyroid with ectopic tissue uptake de-
picted on the post-radioiodine therapy 131I scan.
Methods of Calculation
As part of the diagnostic evaluation, thyroid scans were
performed with either iodine-123 (123I) or technetium-99m
(99mTc) radiotracers using hybrid single-photon emission
computed tomography/computed tomography (SPECT/CT)
that confirmed the presence of a lingual thyroid and absence of
an orthotopic thyroid gland in all patients. One patient also had
concurrent subhyoid ectopic thyroid tissue. Measurement of
1Nuclear Medicine/Radiology, University of Michigan, Ann Arbor, Michigan.
2Nuclear Medicine Service, Department of Veterans Affairs Health System, Ann Arbor, Michigan.
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24-hour radioactive iodine uptake (RAIU) was performed in
all patients. The target volume of therapy was determined by
tridimensional anatomic measurements (Anterior-Posterior
(A-P) · Transverse (TV) · Cranial-Caudal (C-C)) of lingual
thyroid tissue using the CT component of the SPECT/CT
scans, based on an ellipsoid (p/6 ·A-P · TV ·C-C)model (8).
In clinical practice, soft-tissue density is approximated at
1 g/mL. Therefore, the volumetricmeasurements of the lingual
thyroid were approximated to the thyroid tissue mass.
A therapeutic 131I activity was used calculated to deliver a
dose of 0.3 mCi per gram of thyroid tissue retained in the
lingual thyroid gland at 24 hours by the formula:
Therapeutic131I
activity (mCi)
¼ 0:3mCi · target thyroid tissuemass (g)
RAIU
According to this formula, the prescribed therapy 131I dose
is directly proportional to the mass of thyroid tissue and
inversely proportional to the RAIU (9). The intended dos-
ing factor of 0.3 mCi per gram of thyroid tissue is a strategy
used in pediatric hyperthyroidism when there is an em-
phasis on achieving successful RAI treatment with a single
therapy administration (10). To optimize RAIU, patients
were prepared with a low-iodine diet for one week prior to
RAIU and subsequent administration of 131I therapy with
the intent of maximizing radioiodine uptake and reducing
the therapeutic 131I dose. In addition, levothyroxine (LT4)
withdrawal for four weeks was performed with the goal
of increasing the 131I uptake and the retention in the lin-
gual thyroid tissue. Liquid 131I was used for treatment,
with therapeutic 131I doses prepared on-site by the nuclear
pharmacist.
The information obtained by SPECT/CT on the size of the
lingual thyroid tissue and the 24-hour RAIU measurement
within the glandular tissue may contribute valuable data that
can guide selection of the therapeutic 131I dose, by high-
lighting potential problems with RAI treatment (e.g., very
low uptake or very large ectopic deposits). In two patients,
the actual administered RAI dose used was higher than the
calculated dose. Influenced by prior reports that described the
need for significantly higher doses of 131I administration for
treatment of lingual thyroids, and with the intention of
achieving rapid resolution of oropharyngeal obstructive
symptoms, the treating clinician used a higher dose than in-
dicated by the calculations to maximize the chance of suc-
cessful treatment with a single RAI therapy. Dosing of RAI
based solely on calculations obtained from SPECT/CT in-
formation still needs to be further investigated in this rare
condition.
Patients
Patient 1
A 20-year-old woman presented with six to eight months of
progressive dysphagia, intermittent odynophagia, and frequent
upper respiratory infections. Her past medical history was
significant for diagnosis of a lingual thyroid at three years of
age. Evaluation for a sore throat at the time revealed the
presence of a mass at the base of the tongue, which was proven
to be thyroid tissue by direct biopsy. She was hypothyroid and
was placed on LT4 treatment. She had an uneventful clinical
course throughout her childhood and adolescence, but in early
adulthood presented with progressive obstructive oropharyn-
geal symptoms with difficulties swallowing some solid foods,
including tablets, which tended to ‘‘stick’’ at the base of the
tongue. She did not report problems with liquids. After initial
evaluation by an otolaryngologist, she was referred for non-
surgical management of the lingual thyroid. Physical exami-
nation revealed the presence of an approximately 2.0 cmfleshy
mucosal nodule in the midline of the posterior tongue that dis-
placed the uvula to the right. The mass was easily visualized
when the patient protruded her tongue. Her TSHwas 1.1mIU/L,
free triiodothyronine (fT3) was 2.7 pg/mL, and free thyroxine
(fT4) was 1.43 ng/dL while taking 0.075mg of LT4 daily.
She underwent four weeks of LT4 withdrawal, resulting in
endogenous hypothyroidism and an elevation of her TSH to
15.0 mIU/L. A thyroid scan performed after administration
FIG. 1. Baseline radioiodine (RAI) scintigraphy after oral administration of 0.4 mCi of iodine-123 (123I) was performed at
4 and 24 hours. (A) Planar (left) and pinhole (right) images demonstrate absence of uptake in the expected location of the
thyroid gland and an intense focus of RAI uptake in the midline of the upper neck (arrows) overlying the oral cavity. (B) 123I
single-photon emission computed tomography/computed tomography (SPECT/CT) fusion images, axial (upper left), and
sagittal (upper right) performed at four hours for anatomical correlation precisely localized radioiodine uptake in a soft-
tissue mass in the base of the tongue (arrows and arrowheads), with higher attenuation than surrounding soft tissue on the
corresponding CT axial (lower left) and sagittal (lower right). Findings were consistent with a diagnosis of lingual thyroid.
Dimensions of lingual thyroid tissue of 1.9 cm · 1.7 cm · 2.4 cm (calipers have 1 cm gradations) resulted in a calculated
volume of 4.1 g of glandular tissue. The 24-hour 123I thyroid uptake was measured at 10.3%. (C) Six-month follow-up
technetium-99m (99mTc) pertechnetate thyroid scan after RAI therapy, anterior (left) and sagittal (right) projection tomo-
graphic images obtained at 20 minutes after intravenous radiotracer administration demonstrate resolution of prior uptake at
the posterior oral cavity compatible with successful ablation of lingual thyroid.
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of 123I demonstrated focal uptake in the oral cavity (Fig. 1A),
which on SPECT/CT localized to a high attenuation soft-tissue
mass at the base of tongue measuring 1.9 cm· 1.7 cm· 2.4 cm
(Fig. 1B), resulting in a calculated volume of 4.0 g of glandular
tissue. There was absence of an orthotopic, functioning thyroid
gland. The 24-hour 123I uptake was 10.3%. The patient re-
ceived 10.7 mCi of 131I for ablation of her lingual thyroid
(calculated activity 11.7 mCi).
After radioiodine therapy, the patient resumed therapy
with LT4. At a six-month follow-up, she was well and noted
resolution of her previously reported obstructive oropharyn-
geal symptoms. Physical examination revealed near com-
plete disappearance of the lingual thyroid mass. The uvula
had returned to a midline position. A repeat 99mTc pertech-
netate thyroid scan depicted interval resolution of lingual
thyroid tissue (Fig. 1C).
Patient 2
A53-year-old woman presented with globus sensation and a
choking sensation when lying supine that was present for the
past two years. She was diagnosed with hypothyroidism at the
age 40 years, and started on LT4. At the time of evaluation, she
was on 0.112mg daily. Physical examination revealed an
unremarkable oral cavity and oropharynx. Indirect laryngos-
copy revealed a round, symmetric midline mass at the base of
the tongue. No thyroid gland was palpable in the lower neck. A
SPECT/CT 99mTc pertechnetate thyroid scan demonstrated
focal radiotracer accumulation at the base of the tongue, cor-
responding to a rounded, high attenuation, 2.5 cm tongue base
mass without evidence of normal thyroid tissue in the expected
anatomic location at the base of the neck.
A four-week LT4 withdrawal protocol produced subclinical
hypothyroidism (TSH7.81mIU/L; fT4 0.72 ng/dL; fT3 2.4 pg/
mL) and a 123I thyroid scan depicted radioactivity in lingual
thyroid tissue measuring 2.5 cm· 1.8 cm· 2.4 cm, resulting in
a calculated volume of 5.6 g of glandular tissue. A 24-hour 123I
uptake was 13.5%. The patient was treated with 17.5 mCi 131I
(calculated activity 12.6 mCi). She resumed LT4 replace-
ment shortly after RAI therapy. At sixmonths post-radioiodine
therapy, she reported decreased globus sensation. A SPECT/
CT 99mTc pertechnetate thyroid scan showed resolution of the
increased radiotracer uptake in the lingual thyroid tissue, with a
65% interval reduction in size of the soft-tissue nodule at the
tongue base, displaying a CT attenuation similar to that of
surrounding tissues, consistent with residual post-therapy scar
tissue.
Patient 3
A 38-year-old woman presented to medical attention with a
one-year history of globus sensation and progressive dyspha-
gia with both solids and liquids. CT of the neck demonstrated
two homogenously enhancing soft-tissue nodules: the first was
located anterior and parasagittal to the right thyroid cartilage,
and the second was at the midline of the tongue base. A 99mTc
pertechnetate thyroid scan performed five months later re-
vealed increased radiotracer activity corresponding to these
soft-tissues nodules, consistent with thyroid ectopy (Fig. 2).
The anterior right paratracheal ectopic thyroid tissue nodule
measured 3.9 cm· 2.7 cm· 1.5 cm, and the lingual thyroid
measured 1.4 cm· 1.1 cm· 1.2 cm (calculated volume 0.97 g
of glandular tissue). There was absence of an orthotopic,
functioning thyroid gland. Yet, the patient was euthyroid. She
underwent surgical excision of the right paratracheal ectopic
thyroid tissue. However, the endocrine surgeon deferred op-
erating on the lingual thyroid because of potential comorbid-
ities (pain, bleeding, infection) associated with tongue surgery.
Instead, the patient was referred for RAI ablation. Four weeks
after surgery, the patient’s TSH was 71 mIU/L, and her 24-
hour 131I uptake was 3.9%. After low-iodine diet preparation,
she was treated with 15.4 mCi of 131I (calculated activity 7.4
mCi). Following 131I treatment, thyroid hormone replacement
was started with 0.15mg of LT4 daily. A post-therapy 131I
thyroid scan performed five days following treatment showed
intense focal radiotracer uptake at the base of the tongue,
consistent with RAI targeting the lingual thyroid tissue.
The patient demographics, presenting symptoms, imaging,
RAI treatment, and outcomes are summarized in Table 1.
Discussion
Ectopic thyroid tissue is a rare developmental anomaly
affecting embryogenesis of the thyroid in its descent from the
FIG. 2. Baseline scintigraphy was performed 20 minutes after intravenous administration of 5 mCi of 99mTc pertech-
netate. (A) anterior projection tomographic image demonstrates two foci of uptake: one at the level of the oral cavity
(arrowhead), and one at the neck (arrow). (B) 99mTc pertechnetate SPECT/CT fusion axial image (upper) precisely localized
radiotracer uptake in a soft-tissue mass in the base of the tongue (arrowheads) measuring 1.4 cm · 1.1 cm · 1.2 cm, with
higher attenuation than surrounding soft tissue on the corresponding axial CT (lower). (C) SPECT/CT fusion axial image
(upper) and axial CT (lower) localized the second focus of radiotracer uptake to a paratracheal soft tissue mass (arrows)
measuring 1.8 cm· 2.6 cm· 2.1 cm (calipers have 1 cm gradations).
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primitive foregut location to the final pretracheal location in
the neck (1). The thyroid is the first endocrine gland to develop
in the embryo. At approximately the third to fourth gestational
week, the primordium of the medial part of the thyroid forms
as an endodermal thickening of the midline floor of the phar-
ynx between the first and second pharyngeal arches (11–13).
Primitive thyroid cells derived from the thyroid anlage pene-
trate the underlying mesenchymal tissue, migrating caudally
anterior to the hyoid and the laryngeal cartilages to reach the
normal pretracheal position around the seventh gestational
week (2), with fetal thyroid hormone detectable by the 11th
gestational week (13). The proximal segment of the thyr-
oglossal duct regresses between the 5th and 10th weeks of
development, leaving a permanent pit at the dorsum of the
tongue, known as the foramen cecum (14,15).
The prevalence of thyroid ectopia is estimated at
1/100,000–300,000 persons (1). Reported locations of ec-
topic thyroid tissue include lingual, intralingual, sublin-
gual, thyroglossal duct cyst, low neck ectopia, intratracheal,
esophageal, mediastinal, aortic, intracardiac, and abdominal
ectopias. Lingual thyroid is themost common type, accounting
for 90% of reported cases (1). Ectopic lingual thyroid tissue
was first reported in 1869 (3,16,17). About 75% of patients
with a lingual thyroid lack thyroid tissue at the normal cervical
location, and up to 70% are hypothyroid, although hyperthy-
roidism has rarely been reported (1,7). Ectopic thyroid tissue
often has functional insufficiency, and undergoes compensa-
tory enlargement, seen more commonly in patients who have
increased physiological requirement of thyroxine during pe-
riods of active growth, puberty, and pregnancy. In the case of a
lingual thyroid, this increase in size may result in clinical
symptoms of dysphagia, dysphonia, or dyspnea. Occasionally,
obstructive sleep apnea and difficulties with intubation have
been noted in relation to lingual thyroid tissue, whereas ma-
lignancy is rare (1).
Ectopic thyroid tissue is diagnosed using ultrasound (US),
CT, magnetic resonance imaging (MRI), fine-needle aspira-
tion biopsy, and radionuclide scanning, performed in the
context of differential diagnosis of a neck mass or during the
workup of (congenital) hypothyroidism (1,18,19). The pres-
ence of normal thyroid tissue in the neck is easily ascertained
with US or CT. Radionuclide scanning is virtually diagnos-
tic, either with 99mTc pertechnetate, 123I, or 131I through
uptake of this radionuclide by the sodium–iodide symporter
(NIS). This allows the thyroid origin of the ectopic tissue to
be confirmed, and whether there is an orthotopic thyroid
gland present to be assessed (1). The frequency of ectopic
thyroid tissue was studied in 11,905 thyroid scans over a
period of five years for investigation of neck masses or hy-
pothyroidism. The scans were grouped as (i) athyreosis with
absence of discernable thyroid tissue, (ii) a single visualized
site of ectopic thyroid tissue, or (iii) dual ectopia, defined as
the simultaneous presence of two distinct populations of
ectopic thyroid tissue (20). There were 121 patients with
thyroid dysgenesis: 32 athyroid cases, 83 with a single site of
ectopic thyroid tissue, and 6 with dual ectopic thyroid tissue
Table 1. Patient Demographics, Presenting Symptoms, Radionuclide Imaging,
Radioiodine Treatment, and Outcomes
Patient 1 Patient 2 Patient 3
Age (years) 20 53 38
Thyroid function status Hypothyroidism since age of
3 years
Hypothyroidism since the age
of 40 years
Euthyroid
Presenting symptoms 6–8 months of progressive
dysphagia, odynophagia,
and frequent upper
respiratory infections
2-year history of globus
sensation and sensation of
choking when lying supine
1-year history of globus
sensation and dysphagia
Thyroid scan 123I SPECT/CT 123I SPECT/CT 99mTc pertechnetate
SPECT/CT
Findings Hyperdense tongue base mass
(1.9 cm · 1.7 cm ·2.4 cm)
with focal 123I uptake
Absence of orthotopic
thyroid
Hyperdense tongue base mass
(2.5 cm · 1.8 cm ·2.4 cm)
with focal 123I uptake
Absence of orthotopic
thyroid
Hyperdense tongue base mass
(1.4 cm · 1.1 cm · 1.2 cm),
a right anterior paratracheal
mass (1.8 cm· 2.6 cm
· 2.1 cm) with increased
99mTc pertechnetate uptake
Absence of orthotopic
thyroid
24-hour 123I uptake 10.3% 13.5% 3.9% (131I uptake)
Pre-radioiodine ablation
management
4-week withdrawal from LT4,
and 1-week low-iodine diet
4-week withdrawal from LT4,
and 1-week low-iodine diet
Surgical excision of
thyroglossal duct
paratracheal tissue 2
months earlier, then 1-week
low-iodine diet
131I treatment dose 10.7 mCi (liquid) 17.5 mCi (liquid) 15.4 mCi (liquid)
Outcome Interval resolution of lingual
thyroid uptake at 6-month
follow-up
65% reduction in size of
lingual thyroid, with
absence of uptake of 99mTc
at 6-month follow-up
Intense lingual thyroid uptake
on 4-day post-treatment
131I scan
123I, iodine-123; 131I, iodine-131; 99mTc, technetium-99m; LT4, levothyroxine; SPECT/CT, single-photon emission computed
tomography/computed tomography.
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(2). The authors reviewed cases of dual ectopic thyroid tissue
in the neck, noting 42 published cases, comprised of lingual
thyroid in 33%, sublingual in 27%, and subhyoid in 22%
sites, with most patients <30 years old. Of these, 38% were
euthyroid, 33% hypothyroid, and 21% had subclinical hy-
pothyroidism (2). Typically planar or pinhole scintigraphic
imaging is sufficient for diagnosis, although the benefit of 3D
SPECT imaging for lingual thyroid has been reported (21).
Both 99mTc pertechnetate SPECT/CT (7,22,23) or 123I
SPECT/CT scans to depict radioiodine uptake within lingual
thyroid have been reported (24,25). In one case SPECT/CT
clearly demonstrated 99mTc pertechnetate uptake within a
dual thyroid ectopia (lingual and sublingual sites) with ab-
sence of an orthotopic thyroid, similar to the third patient in
this study (23).
Medical management with thyroid hormone replacement
has been used to suppress the growth of lingual thyroid tissue,
and to achieve shrinkage of ectopic thyroid tissue, thus pro-
viding relief of obstructive symptoms. Surgery is the tradi-
tional definitive treatment considered when conservative
management is unsuccessful and if the patient develops
oropharyngeal obstruction, bleeding, sudden enlargement of
the lingual thyroid, or if there is evidence of malignancy (1).
The intent of treatment of lingual thyroid glands consists in
achieving a measurable reduction in the size of the gland with
the goal to relieve symptoms such as dysphagia, odynopha-
gia, or dyspnea. A range of surgical approaches have been
described in the literature (26–28), along with other targeted
therapies (29). Surgical excision has been described via trans-
oral, lateral pharyngotomy, and suprahyoid approaches. The
trans-oral approach is ideally suited for small lingual thyroid
masses located superior to the hyoid. Occasionally a man-
dibulotomy and midline tongue splitting approach is required
for larger lesions (30,31). Bleeding and pain are common, as
is post-surgical scar in excision of larger lesions. Trans-oral
robotic surgery (TORS) and transposition flaps to shift the
lingual thyroid to the lateral oral floor are newer surgical
techniques (1,32). Successful use of TORS was reported in
three symptomatic lingual thyroid patients, with resolution of
symptoms and satisfactory cosmetic results, and no perio-
perative complications or significant bleeding (33). Other
newer targeted treatments such as CO2 laser (34) and
radiofrequency ablation (35) have been reported without
bleeding complications.
RAI is another treatment option for symptomatic lingual
thyroids (1), with the first case of RAI treatment reported by
Schilling et al. in 1950 (36,37). In 1955, two siblings with
lingual thyroid were treated as infants with RAI mixed in
milk, with resultant shrinkage of their masses at the base of
the tongue and resolution of symptoms (38). However, since
that time, RAI therapy has not been widely used due to
concerns regarding radiation exposure in younger individu-
als, the potential of possible airways obstruction after RAI
administration, and concerns about delivering sufficient RAI
activity to ablate the ectopic thyroid tissue. Despite these
concerns, there are multiple reports of successful RAI treat-
ment of lingual thyroid. Danner et al. reviewed their expe-
rience over a six-year period, and found two patients with
lingual thyroid glands treated successfully with 30 mCi and
85 mCi 131I (36). These patients had complete resolution of
symptoms at two months after RAI treatment, with no airway
compromise and subsequent development of hypothyroidism
(follow-up to 18 and 24 months). Iglesias et al. reported a
patient treated with 20 mCi of 131I in two divided 10 mCi
doses separated by nine months (39). The authors did not
specify the therapeutic strategy for RAI dose fractionation,
whether this represented a failure of the first dose of 131I
therapy, or if the RAI therapy was planned as two separate
doses from the outset. Park et al. reported successful treat-
ment of a lingual thyroid with an unspecified 131I dose (24). A
27-year-old woman with a large 8 cm · 6 cm biopsy-
confirmed submental ectopic thyroid mass was imaged with
99mTc pertechnetate and a correlative MRI. She was treated
successfully with 26 mCi 131I, leading to resolution of
swelling and compressive symptoms after three months, and
she was well at two years of follow-up on thyroid hormone
replacement (3). A 48-year-old woman with a 3 cm lingual
thyroid presenting with obstructive sleep apnea and inter-
mittent dyspnea and dysphagia was imaged with 123I SPECT/
CT and was found to have a 24-hour 123I uptake of 14.5%.
Due to high surgical risk, an alternative approach to surgical
excision was preferred, and 30 mCi of 131I was used to ablate
the lingual thyroid successfully, with an 83% reduction in the
volume of the lingual thyroid and resolution of symptoms at
two years of follow-up (24).
This study contributes an additional three cases to the prior
nine cases reported in the literature. This report illustrates the
use of SPECT/CT imaging for the diagnosis and planning of
RAI therapy for ablation of ectopic lingual thyroid. Two of
the patients returned for clinical follow-up: one patient re-
ported resolution of oropharyngeal obstructive symptoms,
and the other patient reported significant improvement of
globus sensation. Follow-up 99mTc pertechnetate scintigra-
phy obtained at six months after 131I therapy demonstrated
successful ablation of all lingual thyroid tissue. The third
patient had two ectopic foci with surgical excision of a sub-
hyoid thyroid mass followed by RAI treatment of a lingual
thyroid. A RAI post-therapy scan depicted lingual thyroid,
although the patient was lost to follow-up. All three patients
reported in this study received oral liquid 131I formulation for
radioablation. The therapeutic 131I formulation (i.e., liquid
vs. capsule) used in other reported series is unknown, as is
whether problems were encountered in administering RAI to
patients with thyroid ectopia.
Each patient had specialist thyroid surgical consultation,
with either an endocrine or otolarygology surgeon, and each
case was discussed at multidisciplinary tumor boards. Lin-
gual thyroid is a rare condition, it is not known how many
surgeries (if any) were performed for lingual thyroids during
the same six-year time period at the authors’ institution. The
decision to select patients for RAI treatment rather than
surgery was based on numerous factors, including symptom-
atology, location of ectopic thyroid tissues, comorbidities,
perceived concerns of complications of RAI versus surgery,
suitability for robotic surgery via the transoral route (33),
RAIU values, and willingness to adhere to post-RAI therapy
radiation safety precautions. Patient preference played an
important role in final decision making. Cases reported in the
literature are characterized by variable approaches for the se-
lection of RAI treatment. They report a range of lingual thyroid
uptake values, and do not specify methods for calculation of
therapeutic 131I activities that ranged between 20 and 85 mCi.
In these cases, the estimation of lingual thyroid tissue volume
was obtained from separately acquired CT or MRI imaging
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studies. The authors’ experience is that hybrid SPECT/CT can
give valuable information regarding size, location, the nature
of the ectopic thyroid tissue, and RAIU values, which can then
assist in the selection of a therapeutic 131I activity using well-
established methods. 99mTc pertechnetate or 123I scintigraphy
with SPECT/CT can also be used in the follow-up assessment
of therapeutic efficacy.
Conclusion
Lingual thyroid is a rare developmental anomaly that may
require size reduction when progressive enlargement of ec-
topic thyroid tissues causes obstructive or compressive oro-
pharyngeal signs and symptoms. Surgery has been traditionally
used to extirpate ectopic thyroid tissue at the base of the ton-
gue. RAI treatment is a safe and effective alternative treatment
to ablate lingual thyroid tissue, with marked improvement or
resolution of symptoms.
Author Disclosure Statement
The authors have nothing to disclose. No competing
financial interests exist.
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